| | | | | | | | | | | | | | | | |
| |
| Issue Date FY: 2025 ( Subtotal = $46,400,037 ) (Continued on the next page) |
| 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | F32NS140209 | Relationship Between Cortical Planning Activity and Disordered Spoken Interaction | 000 | 1 | NIH | 11/20/2024 | $81,592 |
| 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | F32NS140209 | Relationship Between Cortical Planning Activity and Disordered Spoken Interaction | 001 | 1 | NIH | 11/20/2024 | $0 |
| 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01DC017489 | Functional maturation of interneurons that mediate the vestibulo-ocular reflex - Renewal - Resubmission - 1 | 000 | 6 | NIH | 11/26/2024 | $720,183 |
| 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R21AI182549 | Molecular control of tolerogenic dendritic cell function | 000 | 1 | NIH | 11/20/2024 | $246,623 |
| 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01AR079182 | Multinuclear MRI to Assess Joint Homeostasis after Knee Injury | 000 | 3 | NIH | 11/18/2024 | $613,124 |
| 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01AG075272 | Dissecting CEBPB Function with Synthetic Biology and Imaging | 000 | 4 | NIH | 11/20/2024 | $580,863 |
| 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01MH124817 | Maternal health in pregnancy and autism risk - genetic and non-genetic mechanisms | 000 | 6 | NIH | 11/25/2024 | $511,541 |
| 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01DK132395 | Continuous allocation score design for guaranteeing equity and reducing discards in kidney and liver transplantation | 000 | 3 | NIH | 11/28/2024 | $623,463 |
| 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | K23DK124570 | The Role of Enteric Infection in Flares of Inflammatory Bowel Disease | 000 | 5 | NIH | 11/22/2024 | $199,260 |
| 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01NS140233 | Physical, Molecular and Cellular Regulation of Sensory Organ Formation | 000 | 1 | NIH | 12/2/2024 | $563,343 |
| 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01NR018916 | Personalized Dietary Management in Type 2 Diabetes | 000 | 5 | NIH | 11/27/2024 | $586,810 |
| 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01AI188824 | Role of resident macrophages in type II responses and trained immunity | 000 | 1 | NIH | 11/29/2024 | $831,755 |
| 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01NS130035 | Impact of Schwann Cell Pathology on Axon Structure and Function | 000 | 3 | NIH | 11/27/2024 | $464,148 |
| 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01DK127916 | BRinging the Diabetes Prevention Program to GEriatric Populations (BRIDGE) | 000 | 4 | NIH | 11/25/2024 | $619,124 |
| 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01CA279171 | Regulation and tumorigenesis of non-classical RAS oncoproteins - Resubmission | 000 | 2 | NIH | 11/27/2024 | $489,439 |
| 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01CA248896 | Response and resistance to SHP2 inhibitors alone and in combination in Non-Small Cell Lung Cancer | 000 | 5 | NIH | 11/4/2024 | $631,853 |
| 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01CA266345 | Multinuclear MRI to Monitor Breast Cancer Therapy | 000 | 3 | NIH | 11/4/2024 | $632,161 |
| 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01ES031658 | Defining the molecular basis of oncogene-induced replication stress | 000 | 5 | NIH | 11/1/2024 | $419,343 |
| 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01CA257507 | New Approaches to Modeling and Targeting Cyclin E-amplified High-Grade Serous Tubo-Ovarian Carcinoma | 000 | 5 | NIH | 11/1/2024 | $632,989 |
| 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01AI176335 | Interplay between nuclear stress responses and herpesvirus latency | 000 | 2 | NIH | 11/1/2024 | $656,955 |
| 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01CA296978 | Targeting molecular mechanisms of the adeno-to-squamous transition in non-small cell lung cancer treatment adaptation | 000 | 1 | NIH | 1/16/2025 | $703,410 |
| 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01CA277425 | Developing new therapeutic strategies for brain metastasis | 000 | 3 | NIH | 1/13/2025 | $493,877 |
| 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01AI137067 | Translational Regulation of T Regulatory Cells | 000 | 7 | NIH | 1/17/2025 | $701,772 |
| 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | K23HL152013 | Endovascular Health and Platelet Activity in Psoriasis | 000 | 5 | NIH | 1/15/2025 | $171,789 |
| 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01CA269617 | A prospective evaluation of the gut microbiome as a mediator of lymphoma treatment outcome and systemic immunity | 000 | 4 | NIH | 1/17/2025 | $630,506 |
| 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R25NS125593 | Building Research Aspirations In Neurology | 000 | 3 | NIH | 12/5/2024 | $134,928 |
| 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01CA297605 | Targeting LCN2, a novel therapy for lung cancer | 000 | 1 | NIH | 12/3/2024 | $696,569 |
| 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01EY031383 | Unraveling the role of HLA-B51/ERAP1 in Behcet's eye disease | 000 | 5 | NIH | 12/4/2024 | $423,750 |
| 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | K01MD017290 | Prevention of disparities in child psychosocial development in underserved rural families through promotion of early relational health in pediatric health care | 000 | 3 | NIH | 12/4/2024 | $118,886 |
| 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01MH136353 | Dissection of noncoding repeats in psychiatric genetics using synthetic regulatory genomics - Resubmission | 000 | 1 | NIH | 11/29/2024 | $714,615 |
| 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01AG086252 | Understanding Vision Impairment in ESKD to Prevent Cognitive Impairment and Dementia/Alzheimer’s disease: the VIS-HD Cohort Study | 000 | 1 | NIH | 12/12/2024 | $829,211 |
| 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01NS135884 | Benefits of Exercise on Nigrostriatal Dopamine and Motor Behavior | 000 | 2 | NIH | 12/4/2024 | $498,216 |
| 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | F32GM153131 | Non-coding Genomic Determinants of Adipogenesis | 000 | 2 | NIH | 12/5/2024 | $74,284 |
| 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01EB035762 | Coherence engineering of a human brain interferometer to quantitatively and specifically measure cerebral blood flow | 000 | 1 | NIH | 12/11/2024 | $580,654 |
| 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | P2CES033423 | NYU Collaborative Center In Children's Environmental Health Research and Translation | 000 | 4 | NIH | 12/4/2024 | $847,500 |
| 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01AI085166 | Regulation of T cell exit from non-lymphoid tissues | 000 | 13 | NIH | 12/10/2024 | $511,582 |
| 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01NS131948 | Quantification of Multi-Compartment T1 Relaxation and Magnetization Transfer in Biological Tissue: From Biophysics to Biomarkers for Multiple Sclerosis | 000 | 2 | NIH | 12/6/2024 | $570,975 |
| 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01NS139999 | Childhood Adversity Research Effort in Multiple Sclerosis (CARE.in.MS) | 000 | 1 | NIH | 12/6/2024 | $742,352 |
| 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01CA258697 | Molecular Mechanisms of Fructose-induced Colorectal Cancer Cell Survival | 002 | 5 | NIH | 12/19/2024 | $561,876 |
| 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01DC016834 | Cochlear implants and listening effort: the interaction of cognitive and sensory constraints | 001 | 6 | NIH | 1/8/2025 | $626,839 |
| 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01MH130658 | Dissecting the Synaptic and Cellular Actions of Dopamine in Vivo - Diversity Supplement | 000 | 3 | NIH | 12/19/2024 | $48,552 |
| 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | UM1AI148574 | Establishment of the New York University Vaccine and Treatment Evaluation Unit (NYU VTEU) | 001 | 6 | NIH | 12/20/2024 | $249,587 |
| 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | UM1AI148574 | Establishment of the New York University Vaccine and Treatment Evaluation Unit (NYU VTEU) | 000 | 6 | NIH | 12/19/2024 | $606,446 |
| 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | TL1TR001447 | NRSA Training Core | 000 | 10 | NIH | 12/19/2024 | $748,376 |
| 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01CA298153 | Mapping and targeting 3D regulatory elements in leukemia and lymphoma | 000 | 1 | NIH | 12/13/2024 | $690,772 |
| 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01HL160891 | Chylomicrons and endothelial biology | 000 | 3 | NIH | 12/18/2024 | $745,095 |
| 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01GM056927 | Control of Translation in Herpesvirus Infected Cells - Resubmission - 1 | 000 | 20 | NIH | 12/13/2024 | $392,526 |
| 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01AR083407 | Regulation of inflammation by the ubiquitin proteasome pathway | 000 | 2 | NIH | 12/18/2024 | $546,256 |
| 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01CA266212 | mRNA stability and its impact on hematopoiesis and acute leukemia | 000 | 4 | NIH | 12/18/2024 | $486,121 |
|